Despite these facts, an increasing body of evidence suggests that ENO-1, present on the outer leaflet of the plasma membrane of cancer cells [68], may also modulate pericellular proteolytic activity and thus contribute to cancer progression and metastasis. This evidence concerns the gene ENO1 and cancer.